Trial · NCT03226418
Results by group26
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 26
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Rate of Complete Remission and Mortality in the Entire Cohort of Older Patients | Entire Cohort | 90-Day Mortality | 21.9 | percentage of subjects | |
| Rate of Complete Remission and Mortality in the Entire Cohort of Older Patients | Entire Cohort | Remission | 52.0 | percentage of subjects | |
| Rate of Complete Remission (CR) or CR With Incomplete Count Recovery (CRi) and Mortality in Subsets of Older Patients Who Receive Intensive and Low-intensity Chemotherapy | Group I | 90-Day CR/CRi | 50 | percentage of participants | |
| Rate of Complete Remission (CR) or CR With Incomplete Count Recovery (CRi) and Mortality in Subsets of Older Patients Who Receive Intensive and Low-intensity Chemotherapy | Group II | 90-Day CR/CRi | 52.3 | percentage of participants | |
| Rate of Complete Remission (CR) or CR With Incomplete Count Recovery (CRi) and Mortality in Subsets of Older Patients Who Receive Intensive and Low-intensity Chemotherapy | Group I | 90-Day Mortality | 12.5 | percentage of participants | |
| Rate of Complete Remission (CR) or CR With Incomplete Count Recovery (CRi) and Mortality in Subsets of Older Patients Who Receive Intensive and Low-intensity Chemotherapy | Group II | 90-Day Mortality | 23.1 | percentage of participants | |
| Mortality at 90 Days | Group I | 1 | participants | ||
| Mortality at 90 Days | Group II | 15 | participants | ||
| To Asses the Impact of Treatment Intensity on Early Mortality in Older Patients, Who Receive Risk Stratified Therapy. | Group I | 1 month | 0 | percentage of participants | |
| To Asses the Impact of Treatment Intensity on Early Mortality in Older Patients, Who Receive Risk Stratified Therapy. | Group II | 1 month | 7.7 | percentage of participants | |
| To Asses the Impact of Treatment Intensity on Early Mortality in Older Patients, Who Receive Risk Stratified Therapy. | Group I | 3 month | 12.5 | percentage of participants | |
| To Asses the Impact of Treatment Intensity on Early Mortality in Older Patients, Who Receive Risk Stratified Therapy. | Group II | 3 month | 23.1 | percentage of participants | |
| To Determine Proportion of Patients With Impairments Detected by Geriatric Assessments. | Group I | HCT CI of 3 or greater | 0 | participants | |
| To Determine Proportion of Patients With Impairments Detected by Geriatric Assessments. | Group II | HCT CI of 3 or greater | 40 | participants | |
| To Determine Proportion of Patients With Impairments Detected by Geriatric Assessments. | Group I | SPPB score of 9 or less | 0 | participants | |
| To Determine Proportion of Patients With Impairments Detected by Geriatric Assessments. | Group II | SPPB score of 9 or less | 51 | participants | |
| To Determine Proportion of Patients With Impairments Detected by Geriatric Assessments. | Group I | MoCA Score 25 or less | 0 | participants | |
| To Determine Proportion of Patients With Impairments Detected by Geriatric Assessments. | Group II | MoCA Score 25 or less | 47 | participants | |
| To Determine Proportion of Patients With Impairments Detected by Geriatric Assessments. | Group I | Self-reported ADL Score of 6 or less | 0 | participants | |
| To Determine Proportion of Patients With Impairments Detected by Geriatric Assessments. | Group II | Self-reported ADL Score of 6 or less | 21 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03226418/results